Iterum Therapeutics plc Employee Directory
Pharmaceutical ManufacturingDublin, Ireland11-50 Employees
Iterum Therapeutics plc is an Ireland-based clinical-stage pharmaceutical company focused on developing differentiated anti-infectives to address the global threat of multi-drug resistant pathogens. Its lead program centers on a novel anti-infective compound that has shown potent in vitro activity against a broad range of bacteria, including gram-positive, gram-negative, and anaerobic species that can resist other antibiotics. The company sits within the pharmaceutical manufacturing landscape and is based in Dublin. Its products are intended for use by clinicians and health systems confronting serious and life-threatening infections caused by MDR organisms. In August 2025, Iterum launched Orlynvah, an oral penem antibiotic for uncomplicated urinary tract infections, marking the first oral penem antibiotic brought to the US market.